Initiated Buy X

NKTR Nektar Therapeutics

B. Riley Securities

$4

Initiated Buy X

NKTR Nektar Therapeutics

H.C. Wainwright

$6.50

Initiated Overweight X

NKTR Nektar Therapeutics

Piper Sandler

$7

Resumed Buy X

NKTR Nektar Therapeutics

BTIG Research

$4

Initiated Buy X

NKTR Nektar Therapeutics

Rodman & Renshaw

$2

Resumed Underweight X

NKTR Nektar Therapeutics

JP Morgan

Upgrades Mkt Perform Outperform X

NKTR Nektar Therapeutics

TD Cowen

Upgrades Underperform Hold X

NKTR Nektar Therapeutics

Jefferies

$1.50 $1

Downgrades Hold Underperform X

NKTR Nektar Therapeutics

Jefferies

$3.20 $1.50

Downgrades Neutral Underweight X

NKTR Nektar Therapeutics

JP Morgan

Resumed Hold X

NKTR Nektar Therapeutics

Jefferies

$12 $4

Downgrades Neutral Sell X

NKTR Nektar Therapeutics

Goldman

$3

Downgrades Outperform Mkt Perform X

NKTR Nektar Therapeutics

Cowen

Downgrades Buy Neutral X

NKTR Nektar Therapeutics

Mizuho

$35 $8

Downgrades Neutral Underperform X

NKTR Nektar Therapeutics

BofA Securities

$18 $6

Downgrades Buy Neutral X

NKTR Nektar Therapeutics

BTIG Research

Downgrades Buy Hold X

NKTR Nektar Therapeutics

Stifel

$24 $5

Downgrades Outperform Mkt Perform X

NKTR Nektar Therapeutics

William Blair

Upgrades Perform Outperform X

NKTR Nektar Therapeutics

Oppenheimer

$21

Upgrades Hold Buy X

NKTR Nektar Therapeutics

The Benchmark Company

$20

Upgrades Hold Buy X

NKTR Nektar Therapeutics

Stifel

$22 $24

Resumed Neutral X

NKTR Nektar Therapeutics

Goldman

$24

Downgrades Buy Hold X

NKTR Nektar Therapeutics

The Benchmark Company

Initiated Hold X

NKTR Nektar Therapeutics

Stifel

$18

Downgrades Buy Hold X

NKTR Nektar Therapeutics

Jefferies

$59 $23

Downgrades Overweight Neutral X

NKTR Nektar Therapeutics

JP Morgan

$62 $33

Downgrades Buy Neutral X

NKTR Nektar Therapeutics

Mizuho

$79 $21

Initiated Mkt Perform X

NKTR Nektar Therapeutics

SVB Leerink

$38

Initiated Buy X

NKTR Nektar Therapeutics

Goldman

$62

Downgrades Buy Neutral X

NKTR Nektar Therapeutics

H.C. Wainwright

$54

Reiterated Buy X

NKTR Nektar Therapeutics

H.C. Wainwright

$125 $97

Initiated Buy X

NKTR Nektar Therapeutics

Seaport Global Securities

$120

Resumed Overweight X

NKTR Nektar Therapeutics

Piper Jaffray

$125

Reiterated Buy X

NKTR Nektar Therapeutics

Mizuho

$89 $103

Resumed Buy X

NKTR Nektar Therapeutics

H.C. Wainwright

$125

Reiterated Buy X

NKTR Nektar Therapeutics

Canaccord Genuity

$80 $94

NKTR  Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company that discovers and develops medicines in areas of high unmet medical need. The Company's research and development pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. It leverages its chemistry platform to discover and design new drug candidates. These drug candidates utilize its polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. Its programs include Immuno-oncology (I-O), Immunology, Pain-NKTR-181 and Oncology-ONZEALD. It is developing medicines designed to directly or indirectly modulate the activity of key immune cells, such as cytotoxic T cells and Natural Killer (NK) cells, to increase their numbers and improve their function to recognize and attack cancer cells.